---
schema_version: "secwatch.filing_event.v1"
accession: "0001140361-26-028208"
form_type: "8-K"
ticker: "CRNX"
cik: "0001658247"
company_name: "Crinetics Pharmaceuticals, Inc."
filed_at: "2026-07-10T20:01:22+00:00"
generated_at: "2026-07-10T20:03:18.452355+00:00"
event_type: "m_and_a"
sentiment: "neutral"
materiality_score: 0.75
calibrated_materiality_score: 0.75
confidence: "medium"
source: SEC EDGAR
---

# Crinetics enters into merger agreement with Vertex Pharmaceuticals

## Summary
- Merger agreement signed July 6, 2026; Crinetics to become wholly owned subsidiary of Vertex.
- Non-compete agreements with CEO Scott Struthers, CFO Tobin Schilke, CSO Stephen Betz, CCO Isabel Kalofonos.
- Cash payments at closing: Schilke $140,000, Betz $30,000, Kalofonos $30,000.
- No financial terms (price, premium) disclosed in the filing.

## SEC filing metadata
- accession: 0001140361-26-028208
- form_type: 8-K
- ticker: CRNX
- cik: 0001658247
- company_name: Crinetics Pharmaceuticals, Inc.
- filed_at: 2026-07-10T20:01:22+00:00
- event_type: m_and_a
- sentiment: neutral
- materiality_score: 0.75
- calibrated_materiality_score: 0.75
- confidence: medium
- sec_items: 1.01, 5.02
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1658247/000114036126028208/0001140361-26-028208-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1658247/000114036126028208/crnx-20260706.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001140361-26-028208
- JSON: https://secwatch.observer/filing/0001140361-26-028208.json
- Plain text: https://secwatch.observer/filing/0001140361-26-028208.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.